[Federal Register Volume 81, Number 83 (Friday, April 29, 2016)]
[Notices]
[Pages 25677-25678]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-10028]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2014-N-1050]
Recommendations on the Regulation of Combination Drug Medicated
Feeds; Availability; Reopening of Comment Period; Request for Comments
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice of availability; reopening of comment period; request
for comments.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA or we) is reopening the
comment period and requesting public input on possible modifications to
the current review processes for new animal drug applications (NADAs)
for the use of multiple new animal drugs in combination drug medicated
feeds. We are also announcing the availability of a Center for
Veterinary Medicine (CVM) recommendations document for the animal drug
user fee negotiating committee.
DATES: Submit either electronic or written comments by July 29, 2016.
ADDRESSES: You may submit comments as follows:
Electronic Submissions
Submit electronic comments in the following way:
Federal eRulemaking Portal: http://www.regulations.gov.
Follow the instructions for submitting comments. Comments submitted
electronically, including attachments, to http://www.regulations.gov
will be posted to the docket unchanged. Because your comment will be
made public, you are solely responsible for ensuring that your comment
does not include any confidential information that you or a third party
may not wish to be posted, such as medical information, your or anyone
else's Social Security number, or confidential business information,
such as a manufacturing process. Please note that if you include your
name, contact information, or other information that identifies you in
the body of your comments, that information will be posted on http://www.regulations.gov.
If you want to submit a comment with confidential
information that you do not wish to be made available to the public,
submit the comment as a written/paper submission and in the manner
detailed (see ``Written/Paper Submissions'' and ``Instructions'').
Written/Paper Submissions
Submit written/paper submissions as follows:
Mail/Hand delivery/Courier (for written/paper
submissions): Division of Dockets Management (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
For written/paper comments submitted to the Division of
Dockets Management, FDA will post your comment, as well as any
attachments, except for information submitted, marked and identified,
as confidential, if submitted as detailed in ``Instructions.''
Instructions: All submissions received must include the Docket No.
FDA-2014-N-1050 for ``Regulation of Combination Drug Medicated Feeds.''
Received comments will be placed in the docket and, except for those
submitted as ``Confidential Submissions,'' publicly viewable at http://www.regulations.gov or at the Division of Dockets Management between 9
a.m. and 4 p.m., Monday through Friday.
[[Page 25678]]
Confidential Submissions--To submit a comment with
confidential information that you do not wish to be made publicly
available, submit your comments only as a written/paper submission. You
should submit two copies total. One copy will include the information
you claim to be confidential with a heading or cover note that states
``THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.'' The Agency will
review this copy, including the claimed confidential information, in
its consideration of comments. The second copy, which will have the
claimed confidential information redacted/blacked out, will be
available for public viewing and posted on http://www.regulations.gov.
Submit both copies to the Division of Dockets Management. If you do not
wish your name and contact information to be made publicly available,
you can provide this information on the cover sheet and not in the body
of your comments and you must identify this information as
``confidential.'' Any information marked as ``confidential'' will not
be disclosed except in accordance with 21 CFR 10.20 and other
applicable disclosure law. For more information about FDA's posting of
comments to public dockets, see 80 FR 56469, September 18, 2015, or
access the information at: http://www.fda.gov/regulatoryinformation/dockets/default.htm.
Docket: For access to the docket to read background documents or
the electronic and written/paper comments received, go to http://www.regulations.gov and insert the docket number, found in brackets in
the heading of this document, into the ``Search'' box and follow the
prompts and/or go to the Division of Dockets Management, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
FOR FURTHER INFORMATION CONTACT: Linda M. Wilmot, Center for Veterinary
Medicine (HFV-120), Food and Drug Administration, 7500 Standish Pl.,
Rockville, MD 20855, 240-402-0829, [email protected].
SUPPLEMENTARY INFORMATION: In the Federal Register of September 9, 2014
(79 FR 53431), FDA announced that it was beginning to explore possible
modifications to the current review processes for NADAs for the use of
multiple new animal drugs in combination drug medicated feeds. This
effort is consistent with the stated performance goal in the Animal
Drug User Fee Amendments of 2013 (ADUFA III) goals letter.
In the same notice, FDA announced the opening of a docket to
receive public input. Originally, interested persons were given until
September 9, 2015, to provide comment. In a February 13, 2015 (80 FR
8092), notice of a public meeting on this subject, FDA extended the
comment period until March 31, 2016. At this time, FDA is reopening the
comment period until July 29, 2016.
A summary of FDA recommendations, ``Recommendations on the
Regulation of Combination Drug Medicated Feeds,'' has been placed in
the FDA Docket. Persons with access to the Internet may obtain this
document at the CVM FOIA Electronic Reading Room: http://www.fda.gov/ForIndustry/UserFees/AnimalDrugUserFeeActADUFA/default.htm.
Dated: April 22, 2016.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2016-10028 Filed 4-28-16; 8:45 am]
BILLING CODE 4164-01-P